Quality of life and physical activity in type 1 diabetes

Emma J Cockcroft1, Dillon Chithuranjan2, Parth Narendran3,4

  • 1University of Exeter Medical School, Exeter, EX1 2JP, UK.

BMC Pediatrics
|May 1, 2025
PubMed

Insights

Physical activity interventions show unclear benefits for the quality of life in children with type 1 diabetes (T1D). More research is needed to understand long-term physical and psychological health impacts in this population.

Area of Science:

  • Pediatric Endocrinology
  • Exercise Science
  • Public Health

Background:

  • Type 1 Diabetes (T1D) affects numerous children and young people globally.
  • Physical activity is recognized for its benefits in diabetes management, including improved glycemic control.
  • The impact of physical activity on the quality of life (QoL) for children with T1D remains uncertain due to confounding factors.

Purpose of the Study:

  • To systematically review the effects of physical activity interventions on the quality of life in children diagnosed with type 1 diabetes.

Main Methods:

  • A systematic review adhering to PRISMA 2009 guidelines was conducted.
  • Searches were performed across multiple databases (CINAHL, Embase, Medline, PubMed, PsychINFO) from January 1994 to March 2025.
  • Included studies featured interventions in children under 19 with T1D, excluding single sessions, and required a control group; QoL indicators were the primary outcome.

Main Results:

  • Out of 3020 assessed records, only three randomized controlled trials (RCTs) published between 2007 and 2020 met the inclusion criteria.
  • Significant heterogeneity was observed in study designs, methodologies, and reporting across the included trials.
  • The benefits of physical activity on QoL were not consistently demonstrated across the studies.

Conclusions:

  • Limited data exists regarding QoL outcomes and standardized measurement tools for children with T1D.
  • Further research is essential to elucidate the psychological underpinnings necessary for sustained physical and psychological health improvements in pediatric T1D.
  • There is a need for standardized QoL assessment in children with T1D to better evaluate intervention effectiveness.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
204
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
121
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
471
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.5K